Whole-tumor-antigen-pulsed dendritic cells elicit cytotoxic T-cell response against pediatric nasopharyngeal carcinoma in vitro

Medical Oncology

Volumn 26, Issue 1, 2009, Pages 78-85

  Yufeng, Dou ^a   Guocheng, Zhang ^a   Dongliang, Xu ^a   Rong, Fu ^a   Yuhong, Cao ^a   Ruying, Li ^a   Jingshi, Zhou ^a   Xuhong, Zhang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cell culture; Dendritic cells; Immunotherapy; Nasopharyngeal carcinoma; Pediatric oncology

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA ANTIGEN CLASS 1; INTERLEUKIN 4; THYMIDINE; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER STAGING; CASE REPORT; CELL ACTIVITY; CELL MATURATION; CELL PROLIFERATION; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; MONOCYTE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; SCHOOL CHILD; TUMOR CELL; ANTIGEN PRESENTATION; BIOSYNTHESIS; CARCINOMA; CELL SEPARATION; CULTURE TECHNIQUE; CYTOLOGY; CYTOTOXICITY TEST; FLOW CYTOMETRY; IMMUNOLOGY; IMMUNOTHERAPY; METABOLISM; NASOPHARYNX TUMOR;

ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; CARCINOMA; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL SEPARATION; CHILD; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOTHERAPY; INTERFERON-GAMMA; MALE; NASOPHARYNGEAL NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 65549155454     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-008-9093-8     Document Type: Article

References (19)

1. I Ayan E Kaytan N Ayan 2003 Childhood nasopharyngeal carcinoma: from biology to treatment Lancet Oncol 4 1 13 21 10.1016/S1470-2045(03)00956-2 (Pubitemid 36124186)
2. RJ Arceci 2006 Surviving childhood cancer: a special series on the successes and challenges after "cure" Pediatr Blood Cancer 46 2 119 21 10.1002/pbc.20743 (Pubitemid 43076058)
3. J Daoud 2003 Nasopharyngeal carcinoma in childhood and adolescence: analysis of a series of 32 patients treated with combined chemotherapy and radiotherapy Eur J Cancer 39 16 2349 54 10.1016/S0959-8049(03)00512-4 (Pubitemid 37214859)
4. J Banchereau RM Steinman 1998 Dendritic cells and the control of immunity Nature 392 6673 245 52 10.1038/32588 (Pubitemid 28155090)
5. S De Vleeschouwer 2005 Uptake and presentation of malignant glioma tumor cell lysates by monocyte-derived dendritic cells Cancer Immunol Immunother 54 4 372 82 10.1007/s00262-004-0615-8 (Pubitemid 40238931)
6. JS Yu 2004 Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma Cancer Res 64 14 4973 9 10.1158/0008-5472.CAN-03-3505 (Pubitemid 38924545)
7. KC Straathof 2005 Treatment of nasopharyngeal carcinoma with Epstein-Barr virus-specific T lymphocytes Blood 105 5 1898 904 10.1182/blood-2004-07-2975 (Pubitemid 40731770)
8. G Pawelec 2004 Tumour escape: antitumour effectors too much of a good thing? Cancer Immunol Immunother 53 3 262 74 10.1007/s00262-003-0469-5 (Pubitemid 38328050)
9. G Zhou Z Lu JD McCadden HI Levitsky AL Marson 2004 Reciprocal changes in tumor antigenicity and antigen-specific T cell function during tumor progression J Exp Med 200 12 1581 92 10.1084/jem.20041240 (Pubitemid 40094182)
10. K Inaba 1992 Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor J Exp Med 176 6 1693 702 10.1084/jem.176.6.1693
11. DN Hart 1997 Dendritic cells: unique leukocyte populations which control the primary immune response Blood 90 9 3245 87
12. MB Lutz 2000 Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo Eur J Immunol 30 7 1813 22 10.1002/1521-4141(200007)30:7<1813::AID- IMMU1813>3.0.CO;2-8 (Pubitemid 30456177)
13. FJ Hsu 1996 Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells Nat Med 2 1 52 8 10.1038/nm0196-52 (Pubitemid 26028073)
14. FO Nestle 1998 Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells Nat Med 4 3 328 32 10.1038/nm0398-328 (Pubitemid 28144092)
15. B Thurner 1999 Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma J Exp Med 190 11 1669 78 10.1084/jem.190.11.1669 (Pubitemid 30002348)
16. A Kugler 2000 Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids Nat Med 6 3 332 6 10.1038/73193 (Pubitemid 30148627)
17. N Romani 1996 Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability J Immunol Methods 196 2 137 51 10.1016/0022-1759(96)00078-6 (Pubitemid 26306735)
18. B Thurner 1999 Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application J Immunol Methods 223 1 1 15 10.1016/S0022-1759(98)00208-7 (Pubitemid 29096234)
19. H Jonuleit 1997 Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions Eur J Immunol 27 12 3135 42 10.1002/eji.1830271209 (Pubitemid 28018007)